Down-regulation of NRP1 by shRNA in ccRCC cells decreases migration, invasion and experimental human tumor growth [10], while NRP2 down-regulation results in decreased tumor cell extravasation in the lymphatic network and reduced cell metastatic dissemination in immunodeficient models [9]. The gene discussed is NRP2; the disease is neoplasm.